Stoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
Stoke Therapeutics announced that its CEO, Ian F. Smith, and Chief Patient Officer, Jason Hoitt, will present at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026. The biotechnology company focuses on RNA medicine to restore protein expression, with its lead investigational …